相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Safety Monitoring of COVID-19 mRNA Vaccine First Booster Doses Among Persons Aged ≥12 Years with Presumed Immunocompromise Status - United States, January 12, 2022-March 28, 2022
Anne M. Hause et al.
MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT (2022)
Spinal Muscular Atrophy
Stefan Nicolau et al.
SEMINARS IN PEDIATRIC NEUROLOGY (2021)
Delivery of oligonucleotide-based therapeutics: challenges and opportunities
Suzan M. Hammond et al.
EMBO MOLECULAR MEDICINE (2021)
Recent Advances in Oligonucleotide Therapeutics in Oncology
Haoyu Xiong et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
mRNA therapeutics in cancer immunotherapy
Jan D. Beck et al.
MOLECULAR CANCER (2021)
Advances in the Design of (Nano)Formulations for Delivery of Antisense Oligonucleotides and Small Interfering RNA: Focus on the Central Nervous System
Monique C. P. Mendonca et al.
MOLECULAR PHARMACEUTICS (2021)
Endonasal CNS Delivery System for Blood-Brain Barrier Impermeant Therapeutic Oligonucleotides Using Heterotopic Mucosal Engrafting
Grishma Pawar et al.
FRONTIERS IN PHARMACOLOGY (2021)
'N of 1' therapies need a better model
Annemieke Aartsma-Rus
NATURE MEDICINE (2021)
Advances in oligonucleotide drug delivery
Thomas C. Roberts et al.
NATURE REVIEWS DRUG DISCOVERY (2020)
Investigating the pharmacodynamic durability o f GalNAc-siRNA conjugates
Christopher R. Brown et al.
NUCLEIC ACIDS RESEARCH (2020)
The current state and future directions of RNAi-based therapeutics
Ryan L. Setten et al.
NATURE REVIEWS DRUG DISCOVERY (2019)
Messenger RNA therapy as an option for treating metabolic disorders
Randy J. Chandler
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2019)
Lipid nanoparticle-targeted mRNA therapy as a treatment for the inherited metabolic liver disorder arginase deficiency
Brian Truong et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2019)
Patient-Customized Oligonucleotide Therapy for a Rare Genetic Disease
J. Kim et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Chemistry, mechanism and clinical status of antisense oligonucleotides and duplex RNAs
Xiulong Shen et al.
NUCLEIC ACIDS RESEARCH (2018)
Aptamers as targeted therapeutics: current potential and challenges
Jiehua Zhou et al.
NATURE REVIEWS DRUG DISCOVERY (2017)
Safety and immunogenicity of a mRNA rabies vaccine in healthy adults: an open-label, non-randomised, prospective, first-in-human phase 1 clinical trial
Martin Alberer et al.
LANCET (2017)
FDA-Approved Oligonucleotide Therapies in 2017
Cy A. Stein et al.
MOLECULAR THERAPY (2017)
A Highly Durable RNAi Therapeutic Inhibitor of PCSK9
Kevin Fitzgerald et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
FDA Approval of Nusinersen for Spinal Muscular Atrophy Makes 2016 the Year of Splice Modulating Oligonucleotides
Annemieke Aartsma-Rus
NUCLEIC ACID THERAPEUTICS (2017)
Long-term mipomersen treatment is associated with a reduction in cardiovascular events in patients with familial hypercholesterolemia
P. Barton Duell et al.
JOURNAL OF CLINICAL LIPIDOLOGY (2016)
The delivery of therapeutic oligonucleotides
Rudolph L. Juliano
NUCLEIC ACIDS RESEARCH (2016)
Enhancing Endosomal Escape for Intracellular Delivery of Macromolecular Biologic Therapeutics
Peter Lonn et al.
SCIENTIFIC REPORTS (2016)
Multivalent N-Acetylgalactosamine-Conjugated siRNA Localizes in Hepatocytes and Elicits Robust RNAi-Mediated Gene Silencing
Jayaprakash K. Nair et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2014)
Targeted delivery of antisense oligonucleotides to hepatocytes using triantennary N-acetyl galactosamine improves potency 10-fold in mice
Thazha P. Prakash et al.
NUCLEIC ACIDS RESEARCH (2014)
Fomivirsen - Clinical pharmacology and potential drug interactions
RS Geary et al.
CLINICAL PHARMACOKINETICS (2002)
分享论文
